SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Biolife Solutions Inc. – ‘10-K’ for 12/31/23 – ‘EX-97.1’

On:  Thursday, 2/29/24, at 5:16pm ET   ·   For:  12/31/23   ·   Accession #:  1628280-24-8061   ·   File #:  1-36362

Previous ‘10-K’:  ‘10-K’ on 3/31/23 for 12/31/22   ·   Latest ‘10-K’:  This Filing   ·   18 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/29/24  Biolife Solutions Inc.            10-K       12/31/23  131:62M                                    Workiva Inc Wde… FA01/FA

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   3.05M 
 2: EX-4.1      Instrument Defining the Rights of Security Holders  HTML     48K 
 5: EX-10.13    Material Contract                                   HTML     35K 
 3: EX-10.2     Material Contract                                   HTML     64K 
 6: EX-10.21    Material Contract                                   HTML     49K 
 7: EX-10.24    Material Contract                                   HTML     34K 
 8: EX-10.25    Material Contract                                   HTML     86K 
 9: EX-10.26    Material Contract                                   HTML     86K 
10: EX-10.27    Material Contract                                   HTML     86K 
11: EX-10.28    Material Contract                                   HTML     86K 
12: EX-10.29    Material Contract                                   HTML     86K 
 4: EX-10.3     Material Contract                                   HTML     62K 
13: EX-10.30    Material Contract                                   HTML     92K 
14: EX-21.1     Subsidiaries List                                   HTML     34K 
15: EX-23.1     Consent of Expert or Counsel                        HTML     33K 
16: EX-23.2     Consent of Expert or Counsel                        HTML     32K 
21: EX-97.1     Clawback Policy re: Recovery of Erroneously         HTML     47K 
                Awarded Compensation                                             
17: EX-31.1     Certification -- §302 - SOA'02                      HTML     37K 
18: EX-31.2     Certification -- §302 - SOA'02                      HTML     37K 
19: EX-32.1     Certification -- §906 - SOA'02                      HTML     34K 
20: EX-32.2     Certification -- §906 - SOA'02                      HTML     34K 
27: R1          Cover                                               HTML     97K 
28: R2          Audit Information                                   HTML     39K 
29: R3          Consolidated Balance Sheets                         HTML    164K 
30: R4          Consolidated Balance Sheets (Parentheticals)        HTML     58K 
31: R5          Consolidated Statements of Operations               HTML    140K 
32: R6          Consolidated Statements Of Comprehensive Loss       HTML     55K 
33: R7          Consolidated Statements of Shareholders' Equity     HTML    136K 
34: R8          Consolidated Statements of Shareholders' Equity     HTML     35K 
                (Parentheticals)                                                 
35: R9          Consolidated Statements of Cash Flows               HTML    195K 
36: R10         Organization and significant accounting policies    HTML    172K 
37: R11         Impairment of property and equipment and            HTML     45K 
                definite-lived intangible assets                                 
38: R12         Fair value measurement                              HTML     91K 
39: R13         Investments                                         HTML     61K 
40: R14         Inventories                                         HTML     42K 
41: R15         Leases                                              HTML    100K 
42: R16         Assets held for rent                                HTML     44K 
43: R17         Property and equipment                              HTML     46K 
44: R18         Accrued expenses and other current liabilities      HTML     43K 
45: R19         Warranty reserve liability                          HTML     48K 
46: R20         Goodwill and intangible assets                      HTML     75K 
47: R21         Commitments and contingencies                       HTML     42K 
48: R22         Long-term debt                                      HTML     67K 
49: R23         Warrants                                            HTML     45K 
50: R24         Stock-based compensation                            HTML    111K 
51: R25         Income taxes                                        HTML    129K 
52: R26         Acquisitions                                        HTML    109K 
53: R27         Employee benefit plan                               HTML     35K 
54: R28         Subsequent events                                   HTML     36K 
55: R29         Pay vs Performance Disclosure                       HTML     45K 
56: R30         Insider Trading Arrangements                        HTML     80K 
57: R31         Organization and significant accounting policies    HTML    212K 
                (Policies)                                                       
58: R32         Organization and significant accounting policies    HTML    111K 
                (Tables)                                                         
59: R33         Fair value measurement (Tables)                     HTML     87K 
60: R34         Investments (Tables)                                HTML     62K 
61: R35         Inventories (Tables)                                HTML     42K 
62: R36         Leases (Tables)                                     HTML     82K 
63: R37         Assets held for rent (Tables)                       HTML     43K 
64: R38         Property and equipment (Tables)                     HTML     45K 
65: R39         Accrued expenses and other current liabilities      HTML     43K 
                (Tables)                                                         
66: R40         Warranty reserve liability (Tables)                 HTML     46K 
67: R41         Goodwill and intangible assets (Tables)             HTML     81K 
68: R42         Long-term debt (Tables)                             HTML     64K 
69: R43         Warrants (Tables)                                   HTML     40K 
70: R44         Stock-based compensation (Tables)                   HTML     98K 
71: R45         Income taxes (Tables)                               HTML    134K 
72: R46         Acquisitions (Tables)                               HTML     99K 
73: R47         Organization and significant accounting policies -  HTML    106K 
                Narrative (Details)                                              
74: R48         Organization and significant accounting policies -  HTML     54K 
                Schedule of Revenues By Product Line (Details)                   
75: R49         Organization and significant accounting policies -  HTML     44K 
                Summary of Remaining Performance Obligations                     
                (Details)                                                        
76: R50         Organization and significant accounting policies -  HTML     70K 
                Calculation of Basic and Diluted Shares (Details)                
77: R51         Organization and significant accounting policies -  HTML     41K 
                Anti-dilutive (Details)                                          
78: R52         Organization and significant accounting policies -  HTML     42K 
                Summary of Cash, Cash Equivalents, and Restricted                
                Cash (Details)                                                   
79: R53         Organization and significant accounting policies -  HTML     52K 
                Concentrations Risk by Geographic Locations                      
                (Details)                                                        
80: R54         Impairment of property and equipment and            HTML     64K 
                definite-lived intangible assets (Details)                       
81: R55         Fair value measurement - Narrative (Details)        HTML     54K 
82: R56         Fair value measurement - Financial Assets and       HTML     79K 
                Liabilities on Recurring Basis (Details)                         
83: R57         Fair value measurement - Fair Value of Contingent   HTML     48K 
                Consideration Using Level 3 Inputs (Details)                     
84: R58         Investments - Available-For-Sale Marketable         HTML     87K 
                Securities (Details)                                             
85: R59         Investments - Narrative (Details)                   HTML     42K 
86: R60         Inventories (Details)                               HTML     42K 
87: R61         Inventories - Narrative (Details)                   HTML     35K 
88: R62         Leases - Narrative (Details)                        HTML     48K 
89: R63         Leases - Lease Term and Discount Rate (Details)     HTML     42K 
90: R64         Leases - Components of Lease Expense (Details)      HTML     45K 
91: R65         Leases - Maturities of Lease Liabilities (Details)  HTML     72K 
92: R66         Assets held for rent - Schedule of Assets Held for  HTML     43K 
                Rent (Details)                                                   
93: R67         Assets held for rent - Narrative (Details)          HTML     35K 
94: R68         Property and equipment - Schedule of Property and   HTML     50K 
                Equipment (Details)                                              
95: R69         Property and equipment - Narrative (Details)        HTML     35K 
96: R70         Accrued expenses and other current liabilities      HTML     47K 
                (Details)                                                        
97: R71         Warranty reserve liability - Schedule of Product    HTML     43K 
                Warranty Liability (Details)                                     
98: R72         Warranty reserve liability - Narrative (Details)    HTML     35K 
99: R73         Goodwill and intangible assets - Goodwill           HTML     43K 
                (Details)                                                        
100: R74         Goodwill and intangible assets - Intangible Assets  HTML     67K  
                (Details)                                                        
101: R75         Goodwill and intangible assets - Narrative          HTML     38K  
                (Details)                                                        
102: R76         Goodwill and intangible assets - Future             HTML     48K  
                Amortization Expense (Details)                                   
103: R77         Commitments and contingencies (Details)             HTML     57K  
104: R78         Long-term debt - Narrative (Details)                HTML     85K  
105: R79         Long-term debt - Long-term Debt (Details)           HTML     73K  
106: R80         Long-term debt - Maturities of Loans Payable        HTML     54K  
                (Details)                                                        
107: R81         Warrants - Narrative (Details)                      HTML     40K  
108: R82         Warrants - Summary of Warrant Activity (Details)    HTML     43K  
109: R83         Stock-based compensation - Narrative (Details)      HTML    191K  
110: R84         Stock-based compensation - Stock Option Activity    HTML     59K  
                (Details)                                                        
111: R85         Stock-based compensation - Shares Authorized Under  HTML     68K  
                Stock Option Plan (Details)                                      
112: R86         Stock-based compensation - Restricted Stock         HTML     67K  
                Activity (Details)                                               
113: R87         Stock-based compensation - Stock Compensation       HTML     53K  
                Expense (Details)                                                
114: R88         Income taxes - Schedule of Income before Income     HTML     43K  
                Tax, Domestic and Foreign (Details)                              
115: R89         Income taxes - Provision (Benefit) for Income       HTML     61K  
                Taxes (Details)                                                  
116: R90         Income taxes - Narrative (Details)                  HTML     53K  
117: R91         Income taxes - Effective Income Tax Rate            HTML     64K  
                Reconciliation (Details)                                         
118: R92         Income taxes - Deferred Tax Assets and Liabilities  HTML     76K  
                (Details)                                                        
119: R93         Income taxes - Change in Valuation Allowance for    HTML     39K  
                Deferred Tax Assets (Details)                                    
120: R94         Income taxes - Summary of Income Tax Contingencies  HTML     40K  
                (Details)                                                        
121: R95         Acquisitions - Narrative (Details)                  HTML     86K  
122: R96         Acquisitions - Consideration (Details)              HTML     63K  
123: R97         Acquisitions - Fair Value of Net Assets Acquired    HTML    108K  
                (Details)                                                        
124: R98         Acquisitions- Acquired Intangible Assets (Details)  HTML     67K  
125: R99         Acquisitions - Pro Forma Information (Details)      HTML     41K  
126: R100        Employee benefit plan (Details)                     HTML     37K  
128: XML         IDEA XML File -- Filing Summary                      XML    216K  
131: XML         XBRL Instance -- blfs-20231231_htm                   XML   2.85M  
127: EXCEL       IDEA Workbook of Financial Report Info              XLSX    239K  
23: EX-101.CAL  XBRL Calculations -- blfs-20231231_cal               XML    384K 
24: EX-101.DEF  XBRL Definitions -- blfs-20231231_def                XML   1.01M 
25: EX-101.LAB  XBRL Labels -- blfs-20231231_lab                     XML   2.78M 
26: EX-101.PRE  XBRL Presentations -- blfs-20231231_pre              XML   1.64M 
22: EX-101.SCH  XBRL Schema -- blfs-20231231                         XSD    273K 
129: JSON        XBRL Instance as JSON Data -- MetaLinks              727±  1.10M  
130: ZIP         XBRL Zipped Folder -- 0001628280-24-008061-xbrl      Zip   1.04M  


‘EX-97.1’   —   Clawback Policy re: Recovery of Erroneously Awarded Compensation


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C: 
  blfsincentive-basedcompe  
507226237.3 BIOLIFE SOLUTIONS, INC. INCENTIVE-BASED COMPENSATION RECOVERY POLICY 1. Policy Purpose. The purpose of this BioLife Solutions, Inc. (the “Company”) Incentive-Based Compensation Recovery Policy (this “Policy”) is to enable the Company to recover Erroneously Awarded Compensation in the event that the Company is required to prepare an Accounting Restatement. This Policy is intended to comply with the requirements set forth in Listing Rule 5608 of the corporate governance rules of The NASDAQ Stock Market (the “Listing Rule”) and shall be construed and interpreted in accordance with such intent. Unless otherwise defined in this Policy, capitalized terms shall have the meaning ascribed to such terms in Section 7. This Policy shall become effective on December 1, 2023. Where the context requires, reference to the Company shall include the Company’s subsidiaries and affiliates (as determined by the Committee in its discretion). 2. Policy Administration. This Policy shall be administered by the Compensation Committee of the Board (the “Committee”) unless the Board determines to administer this Policy itself. The Committee has full and final authority to make all determinations under this Policy. All determinations and decisions made by the Committee pursuant to the provisions of this Policy shall be final, conclusive and binding on all persons, including the Company, its affiliates, its stockholders and Executive Officers. Any action or inaction by the Committee with respect to an Executive Officer under this Policy in no way limits the Committee’s actions or decisions not to act with respect to any other Executive Officer under this Policy or under any similar policy, agreement or arrangement, nor shall any such action or inaction serve as a waiver of any rights the Company may have against any Executive Officer other than as set forth in this Policy. 3. Policy Application. This Policy applies to all Incentive-Based Compensation received by a person: (a) on or after October 2, 2023, and beginning service as an Executive Officer; (b) who served as an Executive Officer at any time during the performance period for such Incentive-Based Compensation; (c) while the Company had a class of securities listed on a national securities exchange or a national securities association; and (d) during the three completed fiscal years immediately preceding the Accounting Restatement Date. In addition to such last three completed fiscal years, the immediately preceding clause (d) includes any transition period that results from a change in the Company’s fiscal year within or immediately following such three completed fiscal years; provided, however, that a transition period between the last day of the Company’s previous fiscal year end and the first day of its new fiscal year that comprises a period of nine to twelve months shall be deemed a completed fiscal year. For purposes of this Policy, Incentive-Based Compensation is deemed received in the Company’s fiscal period during which the Financial Reporting Measure specified in the Incentive-Based Compensation award is attained, even if the payment or grant of the Incentive-Based Compensation occurs after the end of that period. For the avoidance of doubt, Incentive-Based Compensation that is subject to both a Financial Reporting Measure vesting condition and a service-based vesting condition shall be considered received when the relevant Financial Reporting Measure is achieved, even if the Incentive-Based Compensation continues to be subject to the service-based vesting condition. 4. Policy Recovery Requirement. In the event an Accounting Restatement is required, the Company must recover, reasonably promptly, Erroneously Awarded Compensation, in amounts determined pursuant to this Policy. The Company’s obligation to recover Erroneously Awarded Compensation is not dependent on if or when the Company files the required restated financial statements. Recovery under this Policy with respect to an Executive Officer shall not require the finding of any misconduct by such Executive Officer or such Executive Officer being found responsible for the accounting error leading to an Accounting Restatement. In the event of an Accounting Restatement, the Company shall satisfy the Company’s obligations under this Policy to recover any amount owed from any applicable Executive Officer by exercising its sole and absolute discretion in how to accomplish such recovery. The Company’s


 
2 507226237.3 recovery obligation pursuant to this Section 4 shall not apply to the extent that the Committee, or in the absence of the Committee, a majority of the independent directors serving on the Board, determines that such recovery would be impracticable and: a. The direct expense paid to a third party to assist in enforcing this Policy would exceed the amount to be recovered. Before concluding that it would be impracticable to recover any amount of Erroneously Awarded Compensation based on expense of enforcement, the Company must make a reasonable attempt to recover such Erroneously Awarded Compensation, document such reasonable attempt(s) to recover, and provide that documentation to the Stock Exchange; or b. Recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the registrant, to fail to meet the requirements of Section 401(a)(13) or Section 411(a) of the Code. 5. Policy Prohibition on Indemnification and Insurance Reimbursement. The Company is prohibited from indemnifying any Executive Officer or former Executive Officer against the loss of Erroneously Awarded Compensation. Further, the Company is prohibited from paying or reimbursing an Executive Officer for purchasing insurance to cover any such loss. 6. Required Policy-Related Filings. The Company shall file all disclosures with respect to this Policy in accordance with the requirements of the Federal securities laws, including disclosures required by U.S. Securities and Exchange Commission filings. 7. Definitions. a. “Accounting Restatement” means an accounting restatement due to the material noncompliance of the Company with any financial reporting requirement under the securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period. b. “Accounting Restatement Date” means the earlier to occur of: (i) the date the Board, a committee of the Board, or the officer or officers of the Company authorized to take such action if the Board action is not required, concludes, or reasonably should have concluded, that the Company is required to prepare an Accounting Restatement; and (ii) the date a court, regulator, or other legally authorized body directs the Company to prepare an Accounting Restatement. c. “Board” means the board of directors of the Company. d. “Code” means the U.S. Internal Revenue Code of 1986, as amended. Any reference to a section of the Code or regulation thereunder includes such section or regulation, any valid regulation or other official guidance promulgated under such section, and any comparable provision of any future legislation or regulation amending, supplementing, or superseding such section or regulation. e. “Erroneously Awarded Compensation” means, in the event of an Accounting Restatement, the amount of Incentive-Based Compensation previously received that exceeds the amount of Incentive-Based Compensation that otherwise would have been received had it been determined based on the restated amounts in such Accounting Restatement, and must be


 
3 507226237.3 computed without regard to any taxes incurred or paid by the relevant Executive Officer; provided, however, that for Incentive-Based Compensation based on stock price or total stockholder return, where the amount of Erroneously Awarded Compensation is not subject to mathematical recalculation directly from the information in an Accounting Restatement: (i) the amount of Erroneously Awarded Compensation must be based on a reasonable estimate of the effect of the Accounting Restatement on the stock price or total stockholder return upon which the Incentive-Based Compensation was received; and (ii) the Company must maintain documentation of the determination of that reasonable estimate and provide such documentation to the Stock Exchange. f. “Executive Officer” means the Company’s president, principal financial officer, principal accounting officer (or if there is no such accounting officer, the controller), any vice-president of the Company in charge of a principal business unit, division, or function (such as sales, administration, or finance), any other officer who performs a policy-making function, or any other person who performs similar policy-making functions for the Company. An executive officer of the Company’s parent or subsidiary is deemed an “Executive Officer” if the executive officer performs such policy making functions for the Company. For the avoidance of doubt, “Executive Officer” includes, but is not limited to, any person identified as an executive officer pursuant to Item 401(b) of Regulation S-K under the U.S. Securities Act of 1933, as amended. g. “Financial Reporting Measure” means any measure that is determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements, and any measure that is derived wholly or in part from such measure; provided, however, that a Financial Reporting Measure is not required to be presented within the Company’s financial statements or included in a filing with the U.S. Securities and Exchange Commission to qualify as a “Financial Reporting Measure.” For purposes of this Policy, “Financial Reporting Measure” includes, but is not limited to, stock price and total stockholder return. h. “Incentive-Based Compensation” means any compensation that is granted, earned, or vested based wholly or in part upon the attainment of a Financial Reporting Measure. i. “Stock Exchange” means the national stock exchange on which the Company’s common stock is listed. 8. Acknowledgement. Each Executive Officer shall sign and return to the Company, within 30 calendar days following the later of (i) the effective date of this Policy first set forth above or (ii) the date the individual becomes an Executive Officer, the Acknowledgement Form attached hereto as Exhibit A, pursuant to which the Executive Officer agrees to be bound by, and to comply with, the terms and conditions of this Policy. 9. Committee Indemnification. Any members of the Committee, and any other members of the Board who assist in the administration of this Policy, shall not be personally liable for any action, determination or interpretation made with respect to this Policy and shall be fully indemnified by the Company to the fullest extent under applicable law and Company policy with respect to any such action, determination or interpretation. The foregoing sentence shall not limit any other rights to indemnification of the members of the Board under applicable law or Company policy. 10. Severability. The provisions in this Policy are intended to be applied to the fullest extent of the law. To the extent that any provision of this Policy is found to be unenforceable or invalid under any applicable


 
4 507226237.3 law, such provision shall be applied to the maximum extent permitted, and shall automatically be deemed amended in a manner consistent with its objectives to the extent necessary to conform to any limitations required under applicable law. 11. Amendment; Termination. The Board may amend this Policy from time to time in its sole and absolute discretion and shall amend this Policy as it deems necessary to reflect the Listing Rule. The Board may terminate this Policy at any time. 12. Other Recovery Obligations; General Rights. To the extent that the application of this Policy would provide for recovery of Incentive-Based Compensation that the Company recovers pursuant to Section 304 of the Sarbanes-Oxley Act or other recovery obligations, the amount the relevant Executive Officer has already reimbursed the Company will be credited to the required recovery under this Policy. This Policy shall not limit the rights of the Company to take any other actions or pursue other remedies that the Company may deem appropriate under the circumstances and under applicable law. To the maximum extent permitted under the Listing Rule, this Policy shall be administered in compliance with (or pursuant to an exemption from the application of) Section 409A of the Code. 13. Successors. This Policy is binding and enforceable against all Executive Officers and their beneficiaries, heirs, executors, administrators or other legal representatives. 14. Governing Law; Venue. This Policy and all rights and obligations hereunder are governed by and construed in accordance with the internal laws of the State of Delaware, excluding any choice of law rules or principles that may direct the application of the laws of another jurisdiction. All actions arising out of or relating to this Policy shall be heard and determined exclusively in the Court of Chancery of the State of Delaware or, if such court declines to exercise jurisdiction or if subject matter jurisdiction over the matter that is the subject of any such legal action or proceeding is vested exclusively in the U.S. Federal courts, the U.S. District Court for the District of Delaware.


 
507226237.3 A-1 EXHIBIT A BIOLIFE SOLUTIONS, INC. INCENTIVE-BASED COMPENSATION RECOVERY POLICY ACKNOWLEDGEMENT FORM By signing below, the undersigned acknowledges and confirms that the undersigned has received and reviewed a copy of the BioLife Solutions, Inc. (the “Company”) Incentive-Based Compensation Recovery Policy (the “Policy”). By signing this Acknowledgement Form, the undersigned acknowledges and agrees that the undersigned is and will continue to be subject to the Policy and that the Policy will apply both during and after the undersigned’s employment with the Company. Further, by signing below, the undersigned agrees to abide by the terms of the Policy, including, without limitation, by returning any Erroneously Awarded Compensation (as defined in the Policy) to the Company to the extent required by, and in a manner consistent with, the Policy. Further, by signing below, the undersigned agrees that the terms of the Policy shall govern in the event of any inconsistency between the Policy and the terms of any employment agreement to which the undersigned is a party, or the terms of any compensation plan, program or agreement under which any compensation has been granted, awarded, earned or paid. EXECUTIVE OFFICER Signature Print Name Date


 

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/29/248-K
For Period end:12/31/23
12/1/234
10/2/234
 List all Filings 


18 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/23/23  Biolife Solutions Inc.            8-K:2,5    10/19/23   13:6.9M                                   Workiva Inc Wde… FA01/FA
10/19/23  Biolife Solutions Inc.            8-K:1,3    10/19/23   12:18M                                    Workiva Inc Wde… FA01/FA
 8/16/23  Biolife Solutions Inc.            8-K:5,9     8/15/23   12:180K                                   RDG Filings/FA
 8/15/23  Biolife Solutions Inc.            S-8         8/15/23    6:515K                                   Workiva Inc Wde… FA01/FA
11/09/22  Biolife Solutions Inc.            10-Q        9/30/22  107:10M                                    RDG Filings/FA
 9/12/22  Biolife Solutions Inc.            S-8         9/12/22    5:326K                                   RDG Filings/FA
 4/07/22  Biolife Solutions Inc.            8-K:4,9     4/02/22   12:157K                                   RDG Filings/FA
 3/31/22  Biolife Solutions Inc.            10-K       12/31/21  122:17M                                    RDG Filings/FA
 7/07/21  Biolife Solutions Inc.            S-8         7/07/21    5:340K                                   RDG Filings/FA
 3/31/21  Biolife Solutions Inc.            10-K       12/31/20  109:12M                                    RDG Filings/FA
 3/25/21  Biolife Solutions Inc.            8-K:1,3,9   3/19/21   14:1M                                     RDG Filings/FA
 7/06/17  Biolife Solutions Inc.            8-K:3,5,9   6/30/17    3:63K                                    Toppan Merrill/FA
 5/16/16  Biolife Solutions Inc.            10-Q        3/31/16   60:2.9M                                   Toppan Merrill/FA
 5/05/15  Biolife Solutions Inc.            8-K:1,5,9   5/04/15    4:119K                                   Issuer Direct/FA
 3/24/15  Biolife Solutions Inc.            DEF 14A     5/04/15    1:802K                                   Issuer Direct/FA
 1/30/14  Biolife Solutions Inc.            8-K:3,9     1/29/14    2:34K                                    Issuer Direct/FA
 6/24/13  Biolife Solutions Inc.            S-8         6/24/13    6:560K                                   Issuer Direct/FA
 3/27/13  Biolife Solutions Inc.            DEF 14C     3/07/13    1:199K                                   Issuer Direct/FA
Top
Filing Submission 0001628280-24-008061   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 10:35:00.2am ET